News

14 Small-Cap Biotech Stocks to Consider After the Pullback …

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and […]

Stifel Talks 5 Biotech Stocks – ARIAD Pharmaceuticals, Inc …

Related ARIAMorning Market GainersBenzinga’s Top #PreMarket GainersThe Vetr community has downgraded $ARIA to 3-Stars(Vetr)Related CLVSGoldman Sachs Previews ASCO Cancer Conference With Amgen, Celgene And Clovis OncologyBenzinga’s Volume MoversStifel analyst Brian Klein published abstracts Thursday from the 2015 ASCO annual meeting.Klein’s following comments along with current ratings were intended to provide investors with “meaningful insight into ongoing clinical activities for various […]

This biotech stock is a bargain: Strategist – CNBC.com

This biotech stock is a bargain
Options expert Stacey Gilbert explains why Celgene is trading at a discount to its peers.
Investors have been flocking to biotech stocks this year, with the IBB, the ETF that tracks biotech stocks, up nearly 16 percent. But with high returns come high valuations, except in one name, according to a strategist who closely watches the […]

Biotech Stock Roundup: Alexion to Buy Synageva, FDA Panel Backs …

Mergers & acquisitions once again took center stage in the biotech sector with Alexion (ALXN – Analyst Report) announcing its intention to acquire Synageva (GEVA – Snapshot Report). Meanwhile, there were some important updates on the regulatory and pipeline front from companies like Vertex (VRTX – Analyst Report) and Orexigen (OREX – Analyst Report).Recap of the Week’s Most Important Stories1. […]

Small-Cap Biotech Stocks to Watch (AGTC,THLD,CRIS,OPHT)

I found some very interesting information when conducting research on small-cap biotech stocks. Most disturbing: Well-respected analysts recommended an abundance of small-cap biotech stocks that have since been annihilated. My job is to give readers ideas where they can start research to not only potentially make money, but to stay away from dangerous names. It’s not going to do any […]

Are leveraged ETFs making biotech stocks sick? – CNBC.com

Please choose a subscription
Breaking News
CNBC’s latest news headlines
Morning Squawk
Daily before the bell news roundup
Evening Brief
Daily recap of the day’s top headlines
Guest Alerts
Guest information & reminders for your calendar
Your Wealth
Weekly advice on managing your money
Options Action
Insight from the Options Action panelJob IndustryAdvertising/MarketingAutomotiveCommunications/PRConstruction/ManufacturingEducationFinance/Banking/InsuranceLegalMedia/EntertainmentMedical/Health CareMining/Oil/Gas/UtilitiesGov’t/Non-ProfitReal EstateRetailTechnology/ITTransportation/ShippingTravel/HospitalityOther

View article:

Are leveraged ETFs making biotech stocks sick? – CNBC.com
 […]

Expert: Biogen Is Closing In On The 'Holy Grail' For Biotech Stocks …

Related BIIBBiogen Continues To Decline After Friday’s RoutDid The AAN Meeting Affect Biogen, PTC Therapeutics, GW Pharma Or Isis Pharma?Synageva Q1 Loss Narrower-than-Expected, Pipeline in Focus – Analyst Blog(Zacks)In this week’s episode, Estimize is joined by Joe McCann, a former biotech analyst at CR Intrinsic and the CEO of Slingshot Insights.In the episode, Joe discusses Biogen Inc (NASDAQ: BIIB) new […]